Skip to main content
Premium Trial:

Request an Annual Quote

Australian Patent Office Upholds Two Benitec RNAi Patents

NEW YORK, Aug. 24 (GenomeWeb News) - The Australian Patent Office has reviewed and upheld two RNA interference patents held by Benitec, dealing Nucleonics' patent challenge a blow, Benitec said today.

 

Last year, Nucleonics asked the Commissioner of Patents in Australiato re-examine  Benitec's two RNAi patents, Australian Patent No. 743316 and Australian Innovation Patent No. 2001100608. Nucleonics filed the re-examination requests after being sued for patent infringement in the USby Benitec, which filed suit against Nucleonics and other companies in March of 2004. Both Australian patents were now upheld by the Australian Patent Office.

 

"In conjunction with the recent successful resolution of our contract dispute with Promega, this result will allow us to broadly license our issued patent estate and use any ensuing revenue to focus on developing RNA interference based therapeutics for the treatment of infectious diseases," said Benitec CEO Sara Cunningham in a statement.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.